Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-03 | New | $3,500,000 | $3,500,000 | Other | 06b | SEC link |
| 2022-03-04 | New | $150,000 | $150,000 | Debt Only | 06b | SEC link |
| 2020-10-22 | New | $625,000 | $625,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Richard Fang | Director |
| Mark Goldin | Director, Executive |
| Jeffrey Vaitekunas | Director, Executive, Promoter |